EMPLOYMENT AGREEMENTEmployment Agreement • August 12th, 2021 • Lineage Cell Therapeutics, Inc. • Biological products, (no disgnostic substances) • California
EMPLOYMENT AGREEMENT (this “Agreement”) is made June 8, 2021, by and between Lineage Cell Therapeutics, Inc. (“Company”), a California corporation, and Kevin L. Cook (“Executive”).
FIRST AMENDMENT TO LICENCE AGREEMENTLicence Agreement • August 12th, 2021 • Lineage Cell Therapeutics, Inc. • Biological products, (no disgnostic substances)
CANCER RESEARCH TECHNOLOGY LIMITED a company registered in England and Wales with number 1626049 and registered office at 2 Redman Place, Stratford, London, E20 1JQ, England (“CRT”);
FIRST AMENDMENT TO SEPARATION AND CONSULTING AGREEMENTSeparation and Consulting Agreement • August 12th, 2021 • Lineage Cell Therapeutics, Inc. • Biological products, (no disgnostic substances)
This First Amendment to the Separation and Consulting Agreement (the “Amendment”) is entered into as of May 21, 2021 among Chase C. Leavitt (“Consultant”) and Lineage Cell Therapeutics, Inc., (“Lineage”) (collectively, the “Parties”).
